These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15002046)

  • 1. Treatment of lateralisation and subluxation of the hip in cerebral palsy with Botulinum toxin A: preliminary results based on the analysis of migration percentage data.
    Placzek R; Deuretzbacher G; Meiss AL
    Neuropediatrics; 2004 Feb; 35(1):6-9. PubMed ID: 15002046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of development of hip joint instability in patients with the spastic form of juvenile cerebral palsy].
    Sindelárová R; Poul J
    Acta Chir Orthop Traumatol Cech; 2001; 68(3):176-83. PubMed ID: 11706540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection.
    Massin M; Allington N
    J Pediatr Orthop; 1999; 19(3):362-5. PubMed ID: 10344321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin in infantile cerebral palsy].
    Póo P; Galván-Manso M; Casartelli MJ; López-Casas J; Gassió-Subirats RM; Blanco C; Terricabras-Carol L
    Rev Neurol; 2008; 47 Suppl 1():S21-4. PubMed ID: 18767013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of drooling with botulinum toxin type A in cerebral palsy].
    Duarte CS; Alves TR; Azeredo PM; Almeida SI
    Rev Neurol; 2009 Dec 1-15; 49(11):610. PubMed ID: 19921629
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and treatment of hip dysplasia in cerebral palsy.
    Spiegel DA; Flynn JM
    Orthop Clin North Am; 2006 Apr; 37(2):185-96, vi. PubMed ID: 16638449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.
    Molenaers G; Schörkhuber V; Fagard K; Van Campenhout A; De Cat J; Pauwels P; Ortibus E; De Cock P; Desloovere K
    Eur J Paediatr Neurol; 2009 Sep; 13(5):421-9. PubMed ID: 18977158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy.
    Carr LJ
    Dev Med Child Neurol; 2009 Sep; 51(9):687-8. PubMed ID: 19709139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
    Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract]   [Full Text] [Related]  

  • 15. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM; Arbel N
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy.
    Lowe K; Novak I; Cusick A
    Dev Med Child Neurol; 2006 Mar; 48(3):170-5. PubMed ID: 16483391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 20. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.